257 related articles for article (PubMed ID: 21901101)
1. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.
Howie HL; Koop JI; Weese J; Robinson K; Wipf G; Kim L; Galloway DA
PLoS Pathog; 2011 Aug; 7(8):e1002211. PubMed ID: 21901101
[TBL] [Abstract][Full Text] [Related]
2. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
Dacus D; Cotton C; McCallister TX; Wallace NA
J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
[TBL] [Abstract][Full Text] [Related]
4. Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation.
Dacus D; Wallace NA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452526
[TBL] [Abstract][Full Text] [Related]
5. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.
Wallace NA; Robinson K; Howie HL; Galloway DA
PLoS Pathog; 2012; 8(7):e1002807. PubMed ID: 22807682
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
Vats A; Trejo-Cerro O; Massimi P; Banks L
J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
[TBL] [Abstract][Full Text] [Related]
8. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity.
White EA; Kramer RE; Tan MJ; Hayes SD; Harper JW; Howley PM
J Virol; 2012 Dec; 86(24):13174-86. PubMed ID: 23015706
[TBL] [Abstract][Full Text] [Related]
10. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.
Müller-Schiffmann A; Beckmann J; Steger G
J Virol; 2006 Sep; 80(17):8718-28. PubMed ID: 16912319
[TBL] [Abstract][Full Text] [Related]
11. Interaction of HPV E6 oncoproteins with specific proteasomal subunits.
Tomaić V; Ganti K; Pim D; Bauer C; Blattner C; Banks L
Virology; 2013 Nov; 446(1-2):389-96. PubMed ID: 24074603
[TBL] [Abstract][Full Text] [Related]
12. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
Drews CM; Case S; Vande Pol SB
PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
[TBL] [Abstract][Full Text] [Related]
13. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
Brimer N; Drews CM; Vande Pol SB
PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
[TBL] [Abstract][Full Text] [Related]
14. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
Pim D; Tomaic V; Banks L
J Virol; 2009 Oct; 83(19):9863-74. PubMed ID: 19640984
[TBL] [Abstract][Full Text] [Related]
15. Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.
White EA; Walther J; Javanbakht H; Howley PM
J Virol; 2014 Aug; 88(15):8201-12. PubMed ID: 24850740
[TBL] [Abstract][Full Text] [Related]
16. MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells.
Skelin J; Đukić A; Filić V; Hufbauer M; Akgül B; Thomas M; Banks L; Tomaić V
J Med Virol; 2023 Mar; 95(3):e28624. PubMed ID: 36852660
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
18. Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability.
Wallace NA; Robinson K; Galloway DA
J Virol; 2014 Jun; 88(11):6112-27. PubMed ID: 24648447
[TBL] [Abstract][Full Text] [Related]
19. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
20. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
Patel D; Huang SM; Baglia LA; McCance DJ
EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
